DAFNA CAPITAL MANAGEMENT LLC Rigel Pharmaceuticals, Inc. Transaction History

DAFNA CAPITAL MANAGEMENT LLC portfolio value:

$0
portfolio value

DAFNA CAPITAL MANAGEMENT LLC quarter portfolio value change:

+4.42%
quarter

Rigel Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -390.06K shares -441K $1.18 0
Q2 2022 share Decrease -56.47% -506.03K shares -2.23M $1.13 390.06K
Q1 2022 share Increase +1.95% 17.1K shares 350K $2.99 896.1K
Q4 2021 share Increase +8.65% 70K shares -608K $2.68 879K
Q3 2021 share Increase +231.56% 565K shares 1.87M $3.63 809K
Q2 2021 share Decrease -11.43% -31.5K shares 117K $4.34 244K
Q1 2021 share Increase 0.00% 275.5K shares 942K $3.42 275.5K
Q3 2020 share Decrease -100.00% -157.7K shares -289K $2.4 0
Q2 2020 share 0.00% 0 shares 43K $1.83 157.7K
Q1 2020 share 0.00% 0 shares -91K $1.56 157.7K
Q4 2019 share 0.00% 0 shares 42K $2.14 157.7K
Q3 2019 share Increase +14.61% 20.1K shares -64K $1.87 157.7K
Q2 2019 share 0.00% 0 shares 5K $2.61 137.6K
Q1 2019 share 0.00% 0 shares 38K $2.57 137.6K
Q4 2018 share 0.00% 0 shares -126K $2.3 137.6K
Q3 2018 share 0.00% 0 shares 53K $3.21 137.6K
Q2 2018 share Decrease -84.74% -764.33K shares -2.80M $2.83 137.6K
Q1 2018 share Decrease -8.29% -81.54K shares -623K $3.54 901.93K
Q4 2017 share Increase +121.76% 540K shares 2.69M $3.88 983.47K
Q3 2017 share 0.00% 0 shares -85K $2.54 443.47K
Q2 2017 share Decrease -6.34% -30K shares -356K $2.73 443.47K
Q1 2017 share Increase 0.00% 473.47K shares 1.56M $3.31 473.47K
Q4 2016 share Decrease -100.00% -340K shares -1.24M $2.38 0
Q3 2016 share Decrease -81.59% -1.50M shares -2.87M $3.67 340K
Q2 2016 share Decrease -1.57% -29.40K shares 216K $2.23 1.84M
Q1 2016 share Increase +69.09% 766.75K shares 540K $2.08 1.87M